Key result
Altered platelet receptor expression contributes to neuroinflammation and accelerated cognitive decline in Alzheimer's disease.
Why the study?
Disruptions in platelet-mediated inflammation and healing may play a crucial role in Alzheimer's disease and related dementias, highlighting the need to examine platelet roles for potential disease management and intervention.
Platelets and their receptors play a crucial role in neuroinflammation and the progression of Alzheimer's disease, presenting potential new targets for disease management.
Platelet receptor targeting remains unproven for Alzheimer's; extends neuroinflammatory mechanisms but leaves clinical translation open.
Alzheimer's disease (AD) and related dementias (ADRD) collectively affect a significant portion of the aging population worldwide. The pathological progression of AD involves not only the classical hallmarks of amyloid beta (Aβ) plaque buildup and neurofibrillary tangle development but also the effects of vasculature and chronic inflammatory processes. Recently, platelets have emerged as central players in systemic and neuroinflammation. Studies have shown that patients with altered platelet receptor expression exhibit accelerated cognitive decline independent of traditional risk factors. Additionally, platelets from AD patients exhibit heightened unstimulated activation compared to control groups. Platelet granules contain crucial AD-related proteins like tau and amyloid precursor protein (APP). Dysregulation of platelet exocytosis contributes to disease phenotypes characterized by increased bleeding, stroke, and cognitive decline risk. Recent studies have indicated that these effects are not associated with the quantity of platelets present in circulation. This underscores the hypothesis that disruptions in platelet-mediated inflammation and healing processes may play a crucial role in the development of ADRD. A thorough look at platelets, encompassing their receptors, secreted molecules, and diverse roles in inflammatory interactions with other cells in the circulatory system in AD and ADRD, holds promising prospects for disease management and intervention. This review discusses the pivotal roles of platelets in ADRD.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2024) conducted a review in Alzheimer's disease and related dementias. Platelets play a pivotal role in systemic and neuroinflammation in Alzheimer's disease and related dementias, with altered platelet receptor expression contributing to accelerated cognitive decline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: